Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹546.60
8.60 (1.55%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹3.35K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹292.4+86.9%
52W High₹647-15.5%
Current Price
₹546.60
Circuit Limits (10%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹491.94
Upper Circuit₹601.26
Reference Price
₹546.60
Investment Checklist
Ascending Channel on 1D — target ₹563.0
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 37.32 (BUY) with 80.6% confidence
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
81%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
534.68
EMA50
487.17
EMA200
421.45
Price Action
MIXED
NEUTRAL
Higher Highs7
Higher Lows5
Lower Highs2
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹597.00
₹647.00
Support (Below)
₹513.80
₹474.25
₹464.00
₹448.78
₹435.66
Volume Analysis
TrendDECREASING
Change-21.40%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹541.13
3% Risk₹530.20
5% Risk₹519.27
7% Risk (Custom)
₹508.34Technical Levels
1x ATR (Volatility)₹515.13
2x ATR (Swing)₹483.66
3x ATR (Trend)₹452.19
Immediate Support₹513.80
Moving Averages
EMA 9 (Short-term)₹544.33
EMA 20 (Medium-term)₹534.68
EMA 50 (Trend)₹487.17
EMA 200 (Long-term)₹421.45
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹163.5 Cr | ₹66 Cr | ₹166.7 Cr | ₹141.1 Cr |
| Net Profit | ₹4.5 Cr | ₹-1.9 Cr | ₹4.1 Cr | ₹-13.9 Cr |
| EPS | ₹0.74 | — | ₹0.66 | ₹-2.27 |
| Operating Profit | ₹14.4 Cr | ₹8.5 Cr | ₹15.8 Cr | ₹-8.7 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Panacea Biotec Limited | ₹546.60 | -1.55% | — | ₹3.35K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 19 Sept 2024 | Annual General Meeting | AGM |
| 21 Sept 2023 | Annual General Meeting | AGM |
| 19 Sept 2022 | Annual General Meeting | AGM |
| 16 Sept 2021 | Annual General Meeting | AGM |
| 15 Dec 2020 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for PANACEABIO
View AllNEWS
negative
Business Standard - Markets 30d ago
Panacea Biotec Ltd leads losers in 'B' group
Agri-Tech (India) Ltd, Orbit Exports Ltd, Shardul Securities Ltd and Creative Eye Ltd are among the other losers in the BSE's 'B' group today, 10 June 2026.
AGRITECHBSECREATIVEYEORBTEXPPANACEABIOSHARDULTECHZTECHFast Moving Consumer GoodsFinancial Services
positive
Business Standard - Markets 32d ago
Panacea Biotec zooms 60% in 6 days; stock hits new high on huge volumes
In the past two months, the stock price of Panacea Biotec has skyrocketed 101 per cent.
PANACEABIOHealthcare
positive
CNBC TV18 - Markets 32d ago
Panacea Biotech shares up 56% in six sessions; Here are the latest developments
Panacea Biotec is a key partner in the consortium as the developer of DengiAll, a tetravalent live-attenuated dengue vaccine candidate targeting all four dengue virus serotypes and currently in late-stage development in India.
ALLETECPANACEABIOHealthcareInformation Technology